Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22COVID-19+treatment%22&type=Subject&page=11
/vufind/Search/Results?lookfor=%22COVID-19+treatment%22&type=Subject&page=11
Search /vufind/Search2/Results?lookfor=%22COVID-19+treatment%22&type=Subject&page=11
PubPharm (330)
101
Efficacy and safety of XAV-19 for the treatment of moderate COVID-19 : An international, placebo-controlled, double-blind, randomized clinical trial to evaluate the efficacy and safety of 150 mg XAV-19 infusion, in patients with moderate COVID-19: the EUROXAV study - EUROXAV Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
102
A Phase 2/3 Efficacy and Safety Study of PF-07321332/Ritonavir in Nonhospitalized Low-Risk Adult Participants With COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
103
A Phase 2/3 Efficacy and Safety Study of PF-07321332/Ritonavir in Nonhospitalized Low-Risk Adult Participants With COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
104
The safety and efficacy of dapansutrile for the treatment of moderate COVID-19 symptoms : A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Orally Administered Dapansutrile Capsules for the Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome - OLT1177-10
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
105
Joint European Research on active and emerging pandemics : European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial - EU-SolidAct
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
106
A Phase 2/3 Efficacy And Safety Study Of PF-07321332/Ritonavir in Nonhospitalized High Risk Adult Participants With COVID 19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
107
A Phase 2/3 Postexposure Prophylaxis Study of PF-07321332/Ritonavir in Adult Household Contacts of an Individual With Symptomatic COVID-19 : A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF-07321332/RITONAVIR IN PREVENTING SYMPTOMATIC SARS-COV-2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
108
A Phase 2/3 Postexposure Prophylaxis Study of PF-07321332/Ritonavir in Adult Household Contacts of an Individual With Symptomatic COVID-19 : A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF-07321332/RITONAVIR IN PREVENTING SYMPTOMATIC SARS-COV-2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
109
The safety and efficacy of dapansutrile for the treatment of moderate COVID-19 symptoms : A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Orally Administered Dapansutrile Capsules for the Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome - OLT1177-10
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
110
Joint European Research on active and emerging pandemics : European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial - EU-SolidAct
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[33]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
330
Aufsätze
324
E-Artikel
324
E-Ressourcen
6
Gedruckte Aufsätze
Zeitschriftentitel
108
WHO International Clinical Trials Registry Plat...
9
Cureus
7
Trials
4
Breast cancer research and treatment
4
Internal and emergency medicine
4
Molecular and cellular biochemistry
3
AAPS PharmSciTech
3
BMC infectious diseases
3
ClinicalTrials.gov
3
Conflict and health
3
Journal of nephrology
2
BMC genomics
2
BMC psychiatry
2
Biomedical journal
2
Cells
2
Chemical papers
2
EClinicalMedicine
2
Expert opinion on investigational drugs
2
Frontiers in pharmacology
2
Health and Technology
Alle anzeigen ...
weniger ...
Thema
123
COVID-19 treatment
123
Journal Article
111
610
110
Study Type: Interventional
82
Phase: Phase 2
62
Recruitment Status: Authorised-recruitment may ...
53
SARS-CoV-2
50
COVID-19
43
Review
41
Recruitment Status: Not yet recruiting
27
Antiviral Agents
22
covid-19 treatment
18
Medical Condition: Coronavirus Disease 2019 (CO...
18
Medical Condition: SARS-CoV-2 Infection MedDRA ...
18
Phase: Phase 3
15
Medicine
15
R
14
COVID-19 treatments
14
Research Support, Non-U.S. Gov't
11
Medicine (General)
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
11
2024
59
2023
105
2022
102
2021
53
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
325
Englisch
3
Russisch
3
Spanisch
1
Französisch
1
Polnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...